TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34397733

Group type: EXPERIMENTAL
Intervention: MCT oil massage (10 mL/kg/day of MCT oil divided into three applications)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Massage alone
Number of subjects: 48

Group type: COMPARATOR
Intervention: No massage
Number of subjects: 48
Study: 32993528

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided thoracic paravertebral block (PVB) with 20 mL 0.25% bupivacaine as a single administration.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 44
Study: 36127337

Group type: EXPERIMENTAL
Intervention: Single-dose oxytocin (24 international units)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Multiple-dose oxytocin (4 weeks of once-daily nasal spray)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 32715972

Group type: EXPERIMENTAL
Intervention: Non-tourniquet procedure
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (tourniquet procedure)
Number of subjects: 78
Study: 35218301

Group type: EXPERIMENTAL
Intervention: Vitamin D 2000 IU/day (group A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Acitretin 0.5 mg/kg/day (group B)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 24
Study: 32833858

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg
Number of subjects: 302
Study: 33955547

Group type: EXPERIMENTAL
Intervention: Lacto-ovo-vegetarian diet (VD) for 3 months
Number of subjects: 107

Group type: COMPARATOR
Intervention: Mediterranean diet (MD) for 3 months
Number of subjects: 107
Study: 32590942

Group type: EXPERIMENTAL
Intervention: 150 mg rifabutin every other day (E.O.D) with lopinavir/ritonavir
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 300 mg rifabutin every other day (E.O.D) with lopinavir/ritonavir
Number of subjects: 16
Study: 33731069

Group type: EXPERIMENTAL
Intervention: Educational attainment of 13+ years
Number of subjects: 8698

Group type: EXPERIMENTAL
Intervention: Educational attainment of 10-12 years
Number of subjects: 8698

Group type: EXPERIMENTAL
Intervention: Upper family average income (FAI) tertile
Number of subjects: 8698

Group type: EXPERIMENTAL
Intervention: Middle family average income (FAI) tertile
Number of subjects: 8698

Group type: EXPERIMENTAL
Intervention: Occupation as white collar
Number of subjects: 8698
Study: 33681731

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg BID x1day, followed by 200 mg BID x9days
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine with Azithromycin (HCQ/AZ) 500 mg, then 250 mg daily x4days
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control (ascorbic acid (HCQ) and folic acid (AZ))
Number of subjects: 231
Study: 35219715

Group type: EXPERIMENTAL
Intervention: Augmented double WACA lesion set
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single WACA lesion set (Control)
Number of subjects: 0
Study: 34080094

Group type: EXPERIMENTAL
Intervention: Trastuzumab monotherapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Trastuzumab plus chemotherapy
Number of subjects: 55
Study: 32022664

Group type: EXPERIMENTAL
Intervention: Lemborexant 5 mg (LEM5)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg (LEM10)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Zolpidem (ZOL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 100
Study: 35722886

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA) 2 g/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: PLACEBO
Number of subjects: 40
Study: 34225782

Group type: EXPERIMENTAL
Intervention: Routinely recorded data
Number of subjects: 98

Group type: COMPARATOR
Intervention: Data collected using case report forms
Number of subjects: 98
Study: 32573156

Group type: EXPERIMENTAL
Intervention: Ultramicro needle‐knife and cervical spine fine adjusting
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional acupuncture and manipulation
Number of subjects: 86
Study: 35105389

Group type: EXPERIMENTAL
Intervention: 1:1 soya:dairy blend
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1:2 soya:dairy blend
Number of subjects: 16

Group type: COMPARATOR
Intervention: Whey protein
Number of subjects: 16
Study: 33263718

Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 1231

Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 1231
Study: 34498507

Group type: EXPERIMENTAL
Intervention: Eculizumab monotherapy
Number of subjects: 33
Study: 34454582

Group type: EXPERIMENTAL
Intervention: Fascial manipulation (FM) and sequential yoga poses (SYP)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Cervical mobilization/ thoracic manipulation and therapeutic exercises (usual care)
Number of subjects: 160
Study: 34678847

Group type: EXPERIMENTAL
Intervention: Simulation
Number of subjects: 44

Group type: COMPARATOR
Intervention: QuizTime
Number of subjects: 44

Group type: COMPARATOR
Intervention: Experiential
Number of subjects: 44
Study: 34056848

Group type: EXPERIMENTAL
Intervention: Anterior iliac crest bone grafts
Number of subjects: 20

Group type: COMPARATOR
Intervention: Calvarial bone grafts
Number of subjects: 20
Study: 36091679

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily
Number of subjects: 304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 304
Study: 33307947

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam (active control)
Number of subjects: 40
Study: 35263150

Group type: EXPERIMENTAL
Intervention: Short-term radiotherapy (25 Gy in five fractions over 1 week) followed by four cycles of chemotherapy (total neoadjuvant therapy [TNT])
Number of subjects: 599

Group type: COMPARATOR
Intervention: Chemoradiotherapy (50 Gy in 25 fractions over 5 weeks, concurrently with capecitabine [CRT])
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Short-term radiotherapy (TNT)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Chemoradiotherapy (CRT)
Number of subjects: 599
Study: 34524004

Group type: EXPERIMENTAL
Intervention: Apatinib combined with Paclitaxel and Cisplatin (Apa+TP)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Paclitaxel and Cisplatin (TP)
Number of subjects: 126
Study: 32467402

Group type: EXPERIMENTAL
Intervention: Helmet CPAP with HME filter
Number of subjects: 10

Group type: COMPARATOR
Intervention: Helmet CPAP without HME filter
Number of subjects: 10
Study: 34102092

Group type: EXPERIMENTAL
Intervention: Television on National Geographic channel (NG)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Television with MemoRide software (MR)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Television off (TV off)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rest condition
Number of subjects: 10
Study: 33108617

Group type: EXPERIMENTAL
Intervention: Oral semaglutide
Number of subjects: 0
Study: 32970784

Group type: EXPERIMENTAL
Intervention: Group social support intervention via virtual reality, 14 sessions over 6 months, led by community coordinators and volunteers.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Delayed condition (waitlist control group).
Number of subjects: 34
Study: 35303968

Group type: EXPERIMENTAL
Intervention: Mainstream capnography using an inner cup via face mask (novel method)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sidestream capnography (previous method)
Number of subjects: 60
Study: 32693320

Group type: EXPERIMENTAL
Intervention: Cognitive remediation treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy controls (n = 10)
Number of subjects: 26
Study: 34259635

Group type: EXPERIMENTAL
Intervention: Counselor-initiated treatment
Number of subjects: 191

Group type: COMPARATOR
Intervention: Self-paced treatment
Number of subjects: 191
Study: 35561092

Group type: EXPERIMENTAL
Intervention: Real-time remote access to child's glucose and insulin data by healthcare professionals
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Remote consultations during the COVID-19 pandemic
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Real-time data sharing in routine clinical care
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Consultations for closed-loop system users in routine clinical care
Number of subjects: 30
Study: 32725199

Group type: COMPARATOR
Intervention: 12-week regimen
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: 20-week regimen
Number of subjects: 658
Study: 34263385

Group type: EXPERIMENTAL
Intervention: BAK-preserved latanoprost
Number of subjects: 44

Group type: COMPARATOR
Intervention: polyquad-preserved travoprost
Number of subjects: 44
Study: 33559635

Group type: EXPERIMENTAL
Intervention: PSI instrumentation
Number of subjects: 0

Group type: COMPARATOR
Intervention: STD instrumentation
Number of subjects: 0
Study: 34716558

Group type: EXPERIMENTAL
Intervention: Nomograms for predicting overall survival (OS)
Number of subjects: 6376

Group type: EXPERIMENTAL
Intervention: Nomograms for predicting cancer-specific survival (CSS)
Number of subjects: 6376

Group type: EXPERIMENTAL
Intervention: Kaplan-Meier curves for survival outcomes
Number of subjects: 6376
Study: 34948533

Group type: EXPERIMENTAL
Intervention: Giacometti artwork nudge
Number of subjects: 904

Group type: EXPERIMENTAL
Intervention: Thin body shape nudge
Number of subjects: 904

Group type: EXPERIMENTAL
Intervention: Thick body shape nudge
Number of subjects: 904

Group type: EXPERIMENTAL
Intervention: Giacometti nudge
Number of subjects: 904
Study: 32571720

Group type: EXPERIMENTAL
Intervention: FMP2.1/AS02A malaria vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (rabies vaccine)
Number of subjects: 0
Study: 36257912

Group type: EXPERIMENTAL
Intervention: Latanoprost eye drops
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Minoxidil 5% solution
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Latanoprost eye drops and minoxidil 5% solution
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Betamethasone and minoxidil 5% solution
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Betamethasone solution and latanoprost eye drops
Number of subjects: 108

Group type: COMPARATOR
Intervention: Betamethasone solution
Number of subjects: 108
Study: 32380132

Group type: EXPERIMENTAL
Intervention: Single impression (stock tray and irreversible hydrocolloid)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Two‐step impression (custom tray, border molding with compound, and polyether)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Single impression
Number of subjects: 52

Group type: COMPARATOR
Intervention: Two‐step impression
Number of subjects: 52
Study: 37811576

Group type: EXPERIMENTAL
Intervention: Conventional rotary device
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ultrasonic unit
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 80

Group type: COMPARATOR
Intervention: Laser and piezo groups
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Osteotome used
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Trismus
Number of subjects: 80
Study: 34429313

Group type: EXPERIMENTAL
Intervention: Surgeon-led care (usual care)
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: GP-led care
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: eHealth application (Oncokompas)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 353
Study: 32993752

Group type: EXPERIMENTAL
Intervention: Manual acupuncture at specific acupuncture points with penetrating needling, 5 sessions over 3 menstrual cycles
Number of subjects: 300

Group type: COMPARATOR
Intervention: Sham acupuncture with non-penetrating needling at non-acupuncture points, 5 sessions over 3 menstrual cycles
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care with health education and manual acupuncture after 7 menstrual cycles
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Manual acupuncture
Number of subjects: 300
Study: 35195519

Group type: EXPERIMENTAL
Intervention: Rapid test units
Number of subjects: 722

Group type: COMPARATOR
Intervention: Usual-care units
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Rapid test
Number of subjects: 722

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 722
Study: 34406327

Group type: EXPERIMENTAL
Intervention: Paroxetine-mediated G-protein receptor kinase 2 inhibition
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 34702654

Group type: EXPERIMENTAL
Intervention: Mexiletine (200 mg/day up-titrated to 600 mg/day over 18 days)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 25
Study: 33367578

Group type: EXPERIMENTAL
Intervention: CRK contamination from handwashing sinks
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Clinical isolates of CRKP
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: ST789 clone
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: ST11_KL47 sink isolates
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: ST11_KL64 isolates
Number of subjects: 158
Study: 35422046

Group type: EXPERIMENTAL
Intervention: RG formula
Number of subjects: 60
Study: 34147585

Group type: EXPERIMENTAL
Intervention: Active interpretation bias training (IBT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham computerized IBT training
Number of subjects: 44
Study: 32008920

Group type: EXPERIMENTAL
Intervention: Neck dissection (ND) performed on 46% of patients
Number of subjects: 322

Group type: COMPARATOR
Intervention: No neck dissection (ND)
Number of subjects: 322
Study: 35854347

Group type: EXPERIMENTAL
Intervention: 6-week hybrid mindfulness-based intervention (MBI) consisting of 6 weekly 90-min group-based sessions delivered through face-to-face and online approach.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brief education on dementia care (Control group).
Number of subjects: 0
Study: 34476575

Group type: EXPERIMENTAL
Intervention: HEP (liver metastases)
Number of subjects: 18

Group type: COMPARATOR
Intervention: M0 (no distant metastases)
Number of subjects: 18

Group type: COMPARATOR
Intervention: PER (peritoneal carcinomatosis)
Number of subjects: 18
Study: 35297224

Group type: EXPERIMENTAL
Intervention: POI sleep intervention
Number of subjects: 683
Study: 33138867

Group type: EXPERIMENTAL
Intervention: C-IVIG 0.15g/Kg with standard hospital care
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: C-IVIG 0.2g/Kg with standard hospital care
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: C-IVIG 0.25g/Kg with standard hospital care
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: C-IVIG 0.3g/Kg with standard hospital care
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard hospital care only
Number of subjects: 50
Study: 36063140

Group type: EXPERIMENTAL
Intervention: Emergency financial assistance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-receipt of emergency assistance (treatment group who did not receive assistance)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Experimental control group (randomly assigned)
Number of subjects: 0
Study: 33715085

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 80
Study: 32061968

Group type: EXPERIMENTAL
Intervention: Two-hour educational workshop about a patient-centered approach to opioid therapy
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Educational workshop plus a collaborative care intervention delivered by a nurse care manager (NCM)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Control group (educational workshop only)
Number of subjects: 293
Study: 32290858

Group type: EXPERIMENTAL
Intervention: Infection by Chlamydia pneumoniae
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower immunities (elderly individuals)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher immunities (younger individuals)
Number of subjects: 0
Study: 35652491

Group type: EXPERIMENTAL
Intervention: Restrictive IV fluid administration
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 123
Study: 33287772

Group type: EXPERIMENTAL
Intervention: MIP
Number of subjects: 1350

Group type: EXPERIMENTAL
Intervention: MIP+SMS
Number of subjects: 1350

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 1350
Study: 35994868

Group type: EXPERIMENTAL
Intervention: Educational program attended once weekly for 4 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Educational program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual information provided to control group
Number of subjects: 40
Study: 33801705

Group type: EXPERIMENTAL
Intervention: Nefopam 240 mg (Group N240)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Nefopam 120 mg with fentanyl 600 μg (Group NF)
Number of subjects: 78
Study: 35939810

Group type: EXPERIMENTAL
Intervention: Intravenous ensovibep, 600 mg
Number of subjects: 485

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 485
Study: 32899946

Group type: EXPERIMENTAL
Intervention: 6-min walking test with inertial units measuring lower limb kinematics
Number of subjects: 9
Study: 34238397

Group type: EXPERIMENTAL
Intervention: High adiposity category children
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low and average adiposity category children
Number of subjects: 20
Study: 34688253

Group type: EXPERIMENTAL
Intervention: Prior clinical care for migraine (n=94)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: No prior clinical care for migraine (n=23)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Healthy controls (n=36)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Both patient groups (with and without prior care)
Number of subjects: 117
Study: 32456250

Group type: EXPERIMENTAL
Intervention: True air purifiers
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham air purifiers
Number of subjects: 32
Study: 35585374

Group type: EXPERIMENTAL
Intervention: Tofersen (investigational antisense oligonucleotide designed to reduce synthesis of SOD1 protein)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 32554648

Group type: EXPERIMENTAL
Intervention: Anticipatory Care Planning (ACP) through home visits and personalized support plans
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 64
Study: 34483094

Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (BVS)
Number of subjects: 1845

Group type: COMPARATOR
Intervention: XIENCE everolimus-eluting stent (EES)
Number of subjects: 1845

Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (BVS) on DAPT
Number of subjects: 1845
Study: 34675309

Group type: EXPERIMENTAL
Intervention: Topical capsaicin application
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 33114186

Group type: EXPERIMENTAL
Intervention: Whey protein (PRO)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Isoenergetic carbohydrate (CHO)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Water/placebo (H2O)
Number of subjects: 54
Study: 36201973

Group type: EXPERIMENTAL
Intervention: Ultrasound for confirming ETT depth (high placement)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Ultrasound for confirming ETT depth (middle placement)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Ultrasound for confirming ETT depth (deep placement)
Number of subjects: 3
Study: 34495336

Group type: COMPARATOR
Intervention: 400 IU of oral vitamin D3 supplementation daily
Number of subjects: 801

Group type: EXPERIMENTAL
Intervention: 1200 IU of oral vitamin D3 supplementation daily
Number of subjects: 801
Study: 35881629

Group type: EXPERIMENTAL
Intervention: Defense of mental impairment
Number of subjects: 1601

Group type: COMPARATOR
Intervention: Guilty plea
Number of subjects: 1601
Study: 34376917

Group type: EXPERIMENTAL
Intervention: Test food containing anthocyanin, astaxanthin, and lutein, taken as 2 capsules once daily for 6 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo, taken as 2 capsules once daily for 6 weeks
Number of subjects: 44
Study: 36003050

Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus rhamnosus GG (LGG) 1 x 10^10 CFU/daily for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus rhamnosus GG (LGG)
Number of subjects: 100
Study: 32554219

Group type: EXPERIMENTAL
Intervention: IL-6 levels
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: IL-6 tertiles
Number of subjects: 289
Study: 35748547

Group type: EXPERIMENTAL
Intervention: Echium amoenum-Melissa officinalis syrup and fluvoxamine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo syrup and fluvoxamine
Number of subjects: 40
Study: 32486864

Group type: EXPERIMENTAL
Intervention: Laparoscopic Partial Nephrectomy (LPN)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Robot-Assisted Partial Nephrectomy (RAPN)
Number of subjects: 108
Study: 33938966

Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT) with a single dose of 20 Gy
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Whole-breast irradiation (WBI)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Ipsilateral breast tumor recurrence (IBTR)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Contralateral breast event (CBE)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Distant metastasis-free survival (DMFS)
Number of subjects: 214
Study: 32861306

Group type: EXPERIMENTAL
Intervention: Collaborative shared care delivered by trained TFH and primary health-care workers (PHCW)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Collaborative shared care delivered by trained TFH and PHCW
Number of subjects: 307

Group type: COMPARATOR
Intervention: Enhanced care as usual (control)
Number of subjects: 307
Study: 36229604

Group type: EXPERIMENTAL
Intervention: Self-regulation teaching unit based on mental contrasting with implementation intentions; details on dosage and duration not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified; details on intervention not available.
Number of subjects: 0
Study: 33201025

Group type: EXPERIMENTAL
Intervention: 2RDA (1.6 g/kg body weight)
Number of subjects: 26

Group type: COMPARATOR
Intervention: RDA (0.8 g/kg body weight)
Number of subjects: 26